Majority of patients with colorectal cancer do not experience social difficulties
the ONA take:
Although the majority observe no difficulties, a portion of individuals diagnosed with colorectal cancer (CRC) do experience poor social outcomes.
Researchers based at the Leeds Institute of Cancer and Pathology, University of Leeds, St. James's University Hospital, United Kingdom, sent questionnaires to all 12- to 36-month CRC survivors diagnosed in 2010 or 2011 and treated by the English National Health Service. The questionnaire assessed clinical data, sociodemographic information, and included the Social Difficulties Inventory.
The latter inventory is a 16-item scale of social distress that reviews everyday living conditions, self and others subscales, and related items.
Approximately 82% of the 21,802 respondents completed all social distress items. (Overall response rate of the 34,467 individuals contacted was 63.3%.)
Approximately 15% OF individuals reported experiencing social distress. Multivariable analysis indicated that having three or more long-term conditions was a strong precursor to social distress.
It was determined that the majority of individuals diagnosed with CRC experience no social distress, and that the risk factors (clinical and otherwise) can be used to target support for those who are more likely to experience social difficulties.
Although the majority observe no difficulties, a portion of individuals diagnosed with colorectal cancer do experience poor social outcomes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|